Back to search

Article

Treatment of canine visceral leishmaniasis with Milteforan <sup>™</sup> induces <i>Leishmania infantum</i> resistance to miltefosine and amphotericin B

2021-04-08

Abstract excerpt

Visceral leishmaniasis (VL) is the most severe form of leishmaniasis and is caused by Leishmania infantum in the Americas. Since the use of Milteforam™ was authorized to treat canine visceral leishmaniasis (CVL) in Brazil in 2017, there has also been fear of the emergence of parasites resistant to this drug and, through cross-resistance mechanisms, to meglumine antimoniate and amphotericin B. Additionally, the li...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a1b25c9d-4185-5e21-990f-4a4d08140cee
DOI
10.1101/2021.04.08.438938
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Treatment of canine visceral leishmaniasis with Milteforan <sup>™</sup> induces <i>Leishmania infantum</i> resistance to miltefosine and amphotericin BDOI 10.1101/2021.04.08.438938
Therapeutic vaccination reverses severe canine leishmaniasis: a case reportSemantic proximity
Epidemiological Insights: Unraveling Drug Resistance in Leishmania Species through Comprehensive StudiesSemantic proximity
Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantumSemantic proximity
<i>Leishmania</i> DNA Quantification by Real‐time PCR in Naturally Infected Dogs Treated with MiltefosineSemantic proximity
Impact of Genetic Diversity and Genome Plasticity of Leishmania spp. in Treatment and the Search for Novel Chemotherapeutic Targets.Semantic proximity
Leishmaniasis: Prevention, Parasite Detection and TreatmentSemantic proximity
<i>Leishmania</i>vaccines: progress and problemsSemantic proximity
New insights into the life cycle, host cell tropism, and infection amplification of Leishmania spp.Semantic proximity
Increased metacyclogenesis of antimony-resistant <i>Leishmania donovani</i> clinical linesSemantic proximity
Concern for <em>Dirofilaria immitis</em> and Macrocyclic Lactone Loss of Efficacy: Current Situation in the USA and Europe, and Future ScenariosSemantic proximity
Genomic and phenotypic characterization of experimentally selected resistant <i>Leishmania donovani</i> reveals a role for dynamin-1 like protein in the mechanism of resistance to a novel anti-leishmanial compoundSemantic proximity
Antimony susceptible Leishmania donovani: evidence from in vitro drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era.Semantic proximity
Select a neighboring publication to make it the new centre.